Article
High dose daily interferon-alpha induction and secondary adjunction of ribavirin in treatment-naive patients with chronic hepatitis C. A multicentric, randomised, controlled trial.
Gastroenterologie clinique et biologique - 1 Apr 2006
Wartelle-Bladou Claire, Arpurt Jean-Pierre, Renou Christophe, Pariente Alexandre, Pillon Didier, Nalet Bernard, Picon Magali, Glibert André, Chousterman Michel, Grasset Denis, Morin Thierry, Bernard Pierre, Fischer Daniel, Ramdani Mohamed, Lagier Evelyne, Rotily Michel
Abstract excerpt
OBJECTIVES: To evaluate in naive patients with chronic hepatitis C 1- the efficacy and safety of one month interferon alpha (IFN-alpha) induction regimen; 2- the potential virological benefit of a secondary adjunction of ribavirin among HCV RNA negative patients after 20 weeks of IFN therapy, wit...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.